About Lykera Biomed
Lykera biomed project
Lykera is a privately held biotech company based in Barcelona, Spain. The Company is developing biologics for the treatment of cancer by targeting not only the tumour cells but also the stromal cells and tumour angiogenesis.
Lykera's most advanced product, LK-1 is a first in class antibody against the three tumour compartments. LK-1 has already the in vivo preclinical proof-of-principle and it is ready to enter regulatory preclinical phases.
Lykera's vision stands for bringing innovative therapies for cancer treatment based on a global view of cancer. Innovation for future health.
Image Gallery Lykera Biomed 1
Data Lykera Biomed
Created
Spain,
April/2010
Status
Startup
Inversores Lykera Biomed 0
Lykera Biomed no tiene a su equipo agregado
Acceleradoras Lykera Biomed 0
Lykera Biomed no ha pasado por aceleradoras